{"ticker": {"uuid": "4df94284-1220-420e-a52a-fb738f3845e7", "symbol": "RAD", "name": "Radiopharm Theranostics Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Radiopharm Theranostics (ASX:RAD) Jumps as Nuclear-Medicine Interest Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNUHpMeFIyVVRvTzI4RlFOUEVTZG0tckx5ZWVIRFl2eExONXFWOXI2VUhlcjJfR254VVBiallRcEZMb1JJZnhGMjZmYXdfaHBTLVJiWlVvSW9QY25HcnBuTzN3SmZrcUtOX0F2SEhLUldSalZTZmxGR2tuWWFuYVZTdWhQZDlDaWdHbExRSzRSbWo0MFl5LWZ3dWY4UDY5R2dIUXVCNUpGOVp2b3NXTUZJRw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:14:00+00:00", "published_display": "13 Jul 2026 07:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A$5,885,131 R&D tax refund supports Radiopharm Theranostics (Nasdaq: RADX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSVJ0WHdqMURkdlFYQ2tFLTdiTEc1X185LXlwM3UtUmpyek9Hb2NTdlp0ejBFRUxxWWg0VzRwU29CTWFIN3hFZnhrY0hPQ1dibDVoUWJFc1huaUlTZ1dhaE5TYUVnZ1Z4VURnMHVBQmZTeHF4VDc3UHdNeE5qWHFYbTB1OE9CRmpZNHFNR0plYmNfWVhNSFpVUEMyYldLN0hLQlNUZVNhZktTSVlDOUJ2V2FoMURJcjI5SHRuTnpYS3Y?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Starpharma Says Radiopharm Theranostics Collaboration Milestone Triggers AU$500,000 Option Fee", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPV194M2JVYy0yQ05ZaXNGWUN1RmJyeFo5eHh5bzZpaXFKaGpwY0hybVE0dkFPdTZ5SEtZRzN0dXktQkdpNzk0ZlhnTktDWmxMVzRIY0dQYnpmckJ4U1hyMC10UlluWFJubXk3S05DdWkzdHFQSHdqbDlVODVHb0VudXprdWhyNXlyOXBEbllaUG1XOHY5bVlHLV9vOVl0NXJGQU9DUHN1Y0VTMWdhTkhkLWpzMy1fYmRsR0hOZHduc0tqVHc0dzFlQmxQSQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (ASX:RAD): Why Are ASX Penny Stocks Facing a Catalyst Test?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNZmt1WnZFTGIwa3J3ak85YnN6TlNjNk10dkJNRUtIYXc0Q2FZZjRnbjU4MFZxNmxQUFY2YWhNUWR5TURZMng2d2lxS0tUQ09UTTd2cVJmNko5ak5OQlBlbFpCOXNBQUEwdm03R0w3SHlsWkUyempKbEQ4d1NyQ3BKRnpNem84TzhralVBNk90bE56TVhBYUVFMWhLZzhJZFdYMTNybThmMnZxTXE3UE5IOXNQbFhhc1ZMZ0U0?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Despite Recent Gains, Radiopharm Theranostics Insiders Are Still Down AU$29k", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics ADR (RADX): Inside the Clinical Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRGstejdNa3B1OXpsaEJ3dk5ibVJicl9QLXhfSFIyamdxLVdEajNWbG1HeTFZMnBGNWEtOHZZVHFlaXdDU2t4UkI3YkFHeUZ5dmZvVzNiVXJweU1zQzVGZzZRUWxKRG1PUmtHMXVQUVJucFUwTlVvajlCLWFyVWwyLWt2M3dFY0VfOVBHUV9zM2FpOXZfTHhhQlJBb0VMY20zYVRGb2ZNMUlpUks4?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNR2Zxdld0cmtSZjk5M0NSY0Q5MFd3a05UTHBHNHo0Nmc3R25ELUpRS0Voc3NqdXJGTmlHQXFuOFNwN0tQMVdaME1aZ0Q2M28yOFBvZlN5TmR0R0VieGkzNzNqbERFMm9ibXR3YWxIX2dCWnJWQTFEMHlNTkVEVUR1TzUtcW1hem9iX2RTYlNGeUZ1dFdLZEpxOTIwam5qNFRENnFzeWRPRDRHMEtaYi1rcks2NjBDZw?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Granted Ethics Approval for RAD402 Phase 1 Trial to Treat Advanced Prostate Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQaXk5U0h1T2lTaFJRUWk3WlZiVkhEMXJuT1dDRnhHNWVjanpxWXg1SzJsdTZSMVFnZUV5endPUG4wVlBFTFdVUGIyNlVvUVpEUmh0aVd6S3JCNXZnNVQwbTZ5OFZIMksteDdJV3NhQmh0enNLQ3o4ZmtTWmwzSnpRNUJITHluQjZRUXpmY21YcGJsYWwtUVhUZ25ERTE0by1YUXNzQy0wNXlCZFlnNHRzNHIxR055YmtHTVVwQTVHU094aHFZdThJdXpybFFNNm5UZ0dmZWlB?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-11-17T08:00:00+00:00", "published_display": "17 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxQWUdLSVlYTk1oekJFR0t0cWI1NWVEMHNSWlNjZTdwTlhTZmpZTzRNOVpRaTdmU0pqQ1JEVlNBRmlLVTlQemwwOGFhamxRZExXQk5QdWs4Q1RJakpoVmJyRUljYjhxRTdPMEZnTkVCVjRiZVREaUV5NlBkX2xqbXJ0ZjNQWl9kcnVwYmp0ZTN6NHlfVWxrTFcyWXFEMU15OHplWVN3Y1pWa3FBLVBPY1IxeWkzWTBBeW05Z09jM0lzXy1TQVZYOGFTZU80T2d3eDI3RWw1SFNadkM0ODR0R3gyZ2ZERlR3Q3Zxd0thX0lOc2EwQk5RM1lOMm5UY0ZWckVOSmNqVFJ3?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-10-20T07:00:00+00:00", "published_display": "20 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Full Year 2025 Earnings: Beats Expectations", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-20T07:00:00+00:00", "published_display": "20 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 85, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPMk5TdjVqYnctNVJEZ0JGSlZEMnR3RHVEMWlWdUF6aWlhWkotY0d1X0RPZ2NOUWRsOEZneVNpOE5iVFdTdHFjeE1MbWRvcmd0ODYtZ2x1R1M1Mk5fam85RndlTVpGSzBRdUhWa0RKdW5GQ1A4d0dMT05DdDFhUWdPX0txandwQTZZQ1Z1ZXVpR1FaUU1lQkdfdGtlSEhLLUlhRWxmVFB6ejMzcXJMOElWbmUtWQ?oc=5", "source_name": "Investing News Network", "published_at": "2025-07-29T12:20:41+00:00", "published_display": "29 Jul 2025 12:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RADX SEC Filings - Radiopharm Theranostics Ltd 10-K, 10-Q, 8-K Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE5uc0hIUThlTlFGcnpIYzVjb3R2M1pyY3VPZkFoUUZsVUE2dV9LUFlvN0pmMUNkOVB0WnoxaWZxbC13aFpkUUY3cEZGWlNmXzRoWU50d2xpMA?oc=5", "source_name": "Stock Titan", "published_at": "2025-06-29T03:59:20+00:00", "published_display": "29 Jun 2025 03:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNcy00QjE4RE9zaWxJdDBmWHEzLWliTG1TLW9PMC0xZDJSSVgtTjd1U21kT1JjaUpTanJNNXdyYjN5bUVsaEE2MXhXWjZpdWNzaExxMEt3YmV2SXVnbDFBTXQ2UUt3OEZ3RUhLY1k5d3dKSEJvVmRhRk1SekNKeURENTc3NmN2MWZURkZnU3lmWi1EN0Z1YTl0MlhrZVRfZjc0VHlrczZKbi1wUHNWTmhZczlEMjdnT01QbGRRc05kTUk5SWFqMm4waTEtWkJ5QzVNWW5EbElPc2NxZ2huX0J2bW9YLTVVb0RE?oc=5", "source_name": "Investing News Network", "published_at": "2025-06-11T07:00:00+00:00", "published_display": "11 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5lNkpwMXhEbjl0ZG1mU1JhNXE5aExTb2NTN3BJR3liWlpaTURuWG5sakk1ZnlfTGMwRDdkdUtsa2xyejhhTmhCdFJ2WFRiWG5BcEpN?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-26T05:05:28+00:00", "published_display": "26 Apr 2025 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics: Developing Innovative Radiopharmaceuticals for a Highly Underserved Oncology Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNaHlkS2N5V1NoNExBbi1RaDdidHdyOWZjRWhRMl94U1B0Zld1Rkd0UDBMTUUwRWM2TGhvNFBSeU9SWjEtUUEyVDFzNEtsbjBZX0drTzByY25GN0ljS054Unp4c1BYS24yWFphcldTQzB5YU81SFNqMWdEUl9zbkRZWU4yQk1hU1RSem5JQms0dERrcnYzcUo0b3prVVJIN01MTEFOX2szMUUxdzV0TnduamdDMF9EcEFVOGMxb3lxM1JXTFZCU3MzZXNxUjUwbTg?oc=5", "source_name": "Investing News Network", "published_at": "2024-08-07T07:00:00+00:00", "published_display": "07 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics \u2018Extends Runway\u2019 to Key Milestones with AU$70M Investments: Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPYk02aFRnRm1ZZDZqTGxCTjctMlkzdTUtb3E3T3lKRWZPVmhFaHZnRHZtampNRmRmZ01lZ0RTX1BlUzZ3MnJSclhJcnI2UWptdzZHYTU0Z3AyQS1ua0RTM3JrN3NuXzY0cl9iTVZQY3NoMENpVjhqUVUtX1B6RUM3OHpVM0ZPM0RkSjJ3eWQ1dk01dDdNMEtCUW0tMjRhVTdzdHd2MjVJdW81TnRqOFNJakhvbzY?oc=5", "source_name": "Investing News Network", "published_at": "2024-07-31T23:28:32+00:00", "published_display": "31 Jul 2024 23:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Completes A$70 Million Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPZlhNcjVEYXBIZEdnM2xOTngzZjhNcFJUZUdzQk9sb0FxMmdnX0dEN2ktNGJIaWxLQVJPUE5VMW9qLUhQUmo0TktuME5LZExKSF9fdzI2STB2QmFOVm00X09JdlR3MzdSUHFNU3lvbmRaYkxodnRPNi1CbjJVQWY1YVBLU25sd0dmZkE?oc=5", "source_name": "Investing News Network", "published_at": "2024-06-24T07:00:00+00:00", "published_display": "24 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australia\u2019s Radiopharm Theranostics raises AU$50M IPO to advance pipeline of radiopharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOTTVCbDBkQW05RWtIOWpGN0FKNjFpSEkxVGVHUk5aS3R4Q1R5YzFJTFBOaXJ1M0l4bVVFSTc2eFV0RmpMeDJFT1MwZExFdlRpT2s4ZUxfT3BiLUVIaGxoRGpOdUtmZjNEVmZXWFhaTFdHX2J1MHFxSGR1WFdKSWI4a3k3NTJ6RUFSZzA3Z0NHTjU5YkhRMWZlYzh1czdqcUsxRC1JbzJGUjZrTTNhYXRfVEJRVE01Q084clZzVHVVdzVWSFVHQ1ZFc2U4ZFVWQktYTnc?oc=5", "source_name": "BioWorld News", "published_at": "2021-11-23T08:00:00+00:00", "published_display": "23 Nov 2021 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Radiopharm Theranostics (ASX:RAD) Jumps as Nuclear-Medicine Interest Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNUHpMeFIyVVRvTzI4RlFOUEVTZG0tckx5ZWVIRFl2eExONXFWOXI2VUhlcjJfR254VVBiallRcEZMb1JJZnhGMjZmYXdfaHBTLVJiWlVvSW9QY25HcnBuTzN3SmZrcUtOX0F2SEhLUldSalZTZmxGR2tuWWFuYVZTdWhQZDlDaWdHbExRSzRSbWo0MFl5LWZ3dWY4UDY5R2dIUXVCNUpGOVp2b3NXTUZJRw?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T07:14:00+00:00", "published_display": "13 Jul 2026 07:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A$5,885,131 R&D tax refund supports Radiopharm Theranostics (Nasdaq: RADX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOSVJ0WHdqMURkdlFYQ2tFLTdiTEc1X185LXlwM3UtUmpyek9Hb2NTdlp0ejBFRUxxWWg0VzRwU29CTWFIN3hFZnhrY0hPQ1dibDVoUWJFc1huaUlTZ1dhaE5TYUVnZ1Z4VURnMHVBQmZTeHF4VDc3UHdNeE5qWHFYbTB1OE9CRmpZNHFNR0plYmNfWVhNSFpVUEMyYldLN0hLQlNUZVNhZktTSVlDOUJ2V2FoMURJcjI5SHRuTnpYS3Y?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Starpharma Says Radiopharm Theranostics Collaboration Milestone Triggers AU$500,000 Option Fee", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPV194M2JVYy0yQ05ZaXNGWUN1RmJyeFo5eHh5bzZpaXFKaGpwY0hybVE0dkFPdTZ5SEtZRzN0dXktQkdpNzk0ZlhnTktDWmxMVzRIY0dQYnpmckJ4U1hyMC10UlluWFJubXk3S05DdWkzdHFQSHdqbDlVODVHb0VudXprdWhyNXlyOXBEbllaUG1XOHY5bVlHLV9vOVl0NXJGQU9DUHN1Y0VTMWdhTkhkLWpzMy1fYmRsR0hOZHduc0tqVHc0dzFlQmxQSQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (ASX:RAD): Why Are ASX Penny Stocks Facing a Catalyst Test?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNZmt1WnZFTGIwa3J3ak85YnN6TlNjNk10dkJNRUtIYXc0Q2FZZjRnbjU4MFZxNmxQUFY2YWhNUWR5TURZMng2d2lxS0tUQ09UTTd2cVJmNko5ak5OQlBlbFpCOXNBQUEwdm03R0w3SHlsWkUyempKbEQ4d1NyQ3BKRnpNem84TzhralVBNk90bE56TVhBYUVFMWhLZzhJZFdYMTNybThmMnZxTXE3UE5IOXNQbFhhc1ZMZ0U0?oc=5", "source_name": "Kalkine Media", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Despite Recent Gains, Radiopharm Theranostics Insiders Are Still Down AU$29k", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-17T07:00:00+00:00", "published_display": "17 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics ADR (RADX): Inside the Clinical Programs", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRGstejdNa3B1OXpsaEJ3dk5ibVJicl9QLXhfSFIyamdxLVdEajNWbG1HeTFZMnBGNWEtOHZZVHFlaXdDU2t4UkI3YkFHeUZ5dmZvVzNiVXJweU1zQzVGZzZRUWxKRG1PUmtHMXVQUVJucFUwTlVvajlCLWFyVWwyLWt2M3dFY0VfOVBHUV9zM2FpOXZfTHhhQlJBb0VMY20zYVRGb2ZNMUlpUks4?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Highlights 90% Positive RAD101 Interim Data, Eyes Phase III FDA Talks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNR2Zxdld0cmtSZjk5M0NSY0Q5MFd3a05UTHBHNHo0Nmc3R25ELUpRS0Voc3NqdXJGTmlHQXFuOFNwN0tQMVdaME1aZ0Q2M28yOFBvZlN5TmR0R0VieGkzNzNqbERFMm9ibXR3YWxIX2dCWnJWQTFEMHlNTkVEVUR1TzUtcW1hem9iX2RTYlNGeUZ1dFdLZEpxOTIwam5qNFRENnFzeWRPRDRHMEtaYi1rcks2NjBDZw?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Granted Ethics Approval for RAD402 Phase 1 Trial to Treat Advanced Prostate Cancer", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQaXk5U0h1T2lTaFJRUWk3WlZiVkhEMXJuT1dDRnhHNWVjanpxWXg1SzJsdTZSMVFnZUV5endPUG4wVlBFTFdVUGIyNlVvUVpEUmh0aVd6S3JCNXZnNVQwbTZ5OFZIMksteDdJV3NhQmh0enNLQ3o4ZmtTWmwzSnpRNUJITHluQjZRUXpmY21YcGJsYWwtUVhUZ25ERTE0by1YUXNzQy0wNXlCZFlnNHRzNHIxR055YmtHTVVwQTVHU094aHFZdThJdXpybFFNNm5UZ0dmZWlB?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-11-17T08:00:00+00:00", "published_display": "17 Nov 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgJBVV95cUxQWUdLSVlYTk1oekJFR0t0cWI1NWVEMHNSWlNjZTdwTlhTZmpZTzRNOVpRaTdmU0pqQ1JEVlNBRmlLVTlQemwwOGFhamxRZExXQk5QdWs4Q1RJakpoVmJyRUljYjhxRTdPMEZnTkVCVjRiZVREaUV5NlBkX2xqbXJ0ZjNQWl9kcnVwYmp0ZTN6NHlfVWxrTFcyWXFEMU15OHplWVN3Y1pWa3FBLVBPY1IxeWkzWTBBeW05Z09jM0lzXy1TQVZYOGFTZU80T2d3eDI3RWw1SFNadkM0ODR0R3gyZ2ZERlR3Q3Zxd0thX0lOc2EwQk5RM1lOMm5UY0ZWckVOSmNqVFJ3?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-10-20T07:00:00+00:00", "published_display": "20 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Full Year 2025 Earnings: Beats Expectations", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-09-20T07:00:00+00:00", "published_display": "20 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 85, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPMk5TdjVqYnctNVJEZ0JGSlZEMnR3RHVEMWlWdUF6aWlhWkotY0d1X0RPZ2NOUWRsOEZneVNpOE5iVFdTdHFjeE1MbWRvcmd0ODYtZ2x1R1M1Mk5fam85RndlTVpGSzBRdUhWa0RKdW5GQ1A4d0dMT05DdDFhUWdPX0txandwQTZZQ1Z1ZXVpR1FaUU1lQkdfdGtlSEhLLUlhRWxmVFB6ejMzcXJMOElWbmUtWQ?oc=5", "source_name": "Investing News Network", "published_at": "2025-07-29T12:20:41+00:00", "published_display": "29 Jul 2025 12:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RADX SEC Filings - Radiopharm Theranostics Ltd 10-K, 10-Q, 8-K Forms", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE5uc0hIUThlTlFGcnpIYzVjb3R2M1pyY3VPZkFoUUZsVUE2dV9LUFlvN0pmMUNkOVB0WnoxaWZxbC13aFpkUUY3cEZGWlNmXzRoWU50d2xpMA?oc=5", "source_name": "Stock Titan", "published_at": "2025-06-29T03:59:20+00:00", "published_display": "29 Jun 2025 03:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNcy00QjE4RE9zaWxJdDBmWHEzLWliTG1TLW9PMC0xZDJSSVgtTjd1U21kT1JjaUpTanJNNXdyYjN5bUVsaEE2MXhXWjZpdWNzaExxMEt3YmV2SXVnbDFBTXQ2UUt3OEZ3RUhLY1k5d3dKSEJvVmRhRk1SekNKeURENTc3NmN2MWZURkZnU3lmWi1EN0Z1YTl0MlhrZVRfZjc0VHlrczZKbi1wUHNWTmhZczlEMjdnT01QbGRRc05kTUk5SWFqMm4waTEtWkJ5QzVNWW5EbElPc2NxZ2huX0J2bW9YLTVVb0RE?oc=5", "source_name": "Investing News Network", "published_at": "2025-06-11T07:00:00+00:00", "published_display": "11 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics (RADX) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5lNkpwMXhEbjl0ZG1mU1JhNXE5aExTb2NTN3BJR3liWlpaTURuWG5sakk1ZnlfTGMwRDdkdUtsa2xyejhhTmhCdFJ2WFRiWG5BcEpN?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-26T05:05:28+00:00", "published_display": "26 Apr 2025 05:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics: Developing Innovative Radiopharmaceuticals for a Highly Underserved Oncology Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxNaHlkS2N5V1NoNExBbi1RaDdidHdyOWZjRWhRMl94U1B0Zld1Rkd0UDBMTUUwRWM2TGhvNFBSeU9SWjEtUUEyVDFzNEtsbjBZX0drTzByY25GN0ljS054Unp4c1BYS24yWFphcldTQzB5YU81SFNqMWdEUl9zbkRZWU4yQk1hU1RSem5JQms0dERrcnYzcUo0b3prVVJIN01MTEFOX2szMUUxdzV0TnduamdDMF9EcEFVOGMxb3lxM1JXTFZCU3MzZXNxUjUwbTg?oc=5", "source_name": "Investing News Network", "published_at": "2024-08-07T07:00:00+00:00", "published_display": "07 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics \u2018Extends Runway\u2019 to Key Milestones with AU$70M Investments: Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPYk02aFRnRm1ZZDZqTGxCTjctMlkzdTUtb3E3T3lKRWZPVmhFaHZnRHZtampNRmRmZ01lZ0RTX1BlUzZ3MnJSclhJcnI2UWptdzZHYTU0Z3AyQS1ua0RTM3JrN3NuXzY0cl9iTVZQY3NoMENpVjhqUVUtX1B6RUM3OHpVM0ZPM0RkSjJ3eWQ1dk01dDdNMEtCUW0tMjRhVTdzdHd2MjVJdW81TnRqOFNJakhvbzY?oc=5", "source_name": "Investing News Network", "published_at": "2024-07-31T23:28:32+00:00", "published_display": "31 Jul 2024 23:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Radiopharm Theranostics Completes A$70 Million Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPZlhNcjVEYXBIZEdnM2xOTngzZjhNcFJUZUdzQk9sb0FxMmdnX0dEN2ktNGJIaWxLQVJPUE5VMW9qLUhQUmo0TktuME5LZExKSF9fdzI2STB2QmFOVm00X09JdlR3MzdSUHFNU3lvbmRaYkxodnRPNi1CbjJVQWY1YVBLU25sd0dmZkE?oc=5", "source_name": "Investing News Network", "published_at": "2024-06-24T07:00:00+00:00", "published_display": "24 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Australia\u2019s Radiopharm Theranostics raises AU$50M IPO to advance pipeline of radiopharmaceuticals", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOTTVCbDBkQW05RWtIOWpGN0FKNjFpSEkxVGVHUk5aS3R4Q1R5YzFJTFBOaXJ1M0l4bVVFSTc2eFV0RmpMeDJFT1MwZExFdlRpT2s4ZUxfT3BiLUVIaGxoRGpOdUtmZjNEVmZXWFhaTFdHX2J1MHFxSGR1WFdKSWI4a3k3NTJ6RUFSZzA3Z0NHTjU5YkhRMWZlYzh1czdqcUsxRC1JbzJGUjZrTTNhYXRfVEJRVE01Q084clZzVHVVdzVWSFVHQ1ZFc2U4ZFVWQktYTnc?oc=5", "source_name": "BioWorld News", "published_at": "2021-11-23T08:00:00+00:00", "published_display": "23 Nov 2021 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 18, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 14, "score": 54, "total": 18, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 89, "events": [{"event": "general", "label": "Market update", "weight": 8.25, "count": 15}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.02, "latest_week": "2026-07-10", "one_week_move": -5.0, "four_week_move": -5.0, "twelve_week_move": -7.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.241461, "market_dynamics_buy_signal": false, "relative_strength": -19.309712, "fair_value_gap": -52.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 34.8526, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.0% over one week, -5.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 66, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Investing News Network", "count": 5}, {"label": "Stock Titan", "count": 3}, {"label": "simplywall.st", "count": 2}, {"label": "Market source", "count": 2}, {"label": "Kalkine", "count": 1}, {"label": "Moomoo", "count": 1}, {"label": "Kalkine Media", "count": 1}, {"label": "smallcaps.com.au", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 18}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 15}, {"label": "Earnings", "count": 2}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "89/100 classification confidence."}, {"label": "Company focus", "value": "18", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.0% over one week, -5.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Radiopharm Theranostics (ASX:RAD) Jumps as Nuclear-Medicine Interest Builds"}], "updated_at": "2026-07-17T06:19:09.062647+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}